The Black Women's Health Imperative (BWHI) has launched an initiative to address the significantly higher breast cancer mortality rates among Black women in the U.S., particularly across Mississippi, Alabama, Georgia, North Carolina, and South Carolina. Black women are 40% more likely to die from breast cancer than white women, often due to later diagnoses, more aggressive tumor types, and systemic barriers to early detection and timely care. BWHI aims to bridge these gaps through increased awareness, education, and improved access to essential screening services.
The initiative focuses on educating Black women about early detection, including recommending annual mammograms starting at age 40, understanding family history, and encouraging genetic testing for BRCA1 and BRCA2 mutations. BWHI is also advocating for broader access to 3D digital mammography, which offers more precise detection, particularly for women with dense breast tissue. Dr. Ebony Boulware from Duke University School of Medicine and the Duke Clinical Research Institute is leading a study to identify effective interventions for reducing these disparities, examining factors that contribute to differing outcomes.
Beyond education and screening access, BWHI is pushing for policy changes to address systemic issues that impede early detection and treatment. Dr. Karen Winkfield of the Meharry-Vanderbilt Alliance emphasized the need to acknowledge systemic racism creating barriers to care access and understanding disease risk factors. By focusing on awareness, access, and policy advocacy, BWHI seeks to reduce the disproportionate breast cancer mortality burden on Black women and ensure more equitable health outcomes.
